Tysabri Approved By NICE, UK
Main Category: Multiple SclerosisArticle Date: 28 Aug 2007 - 2:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
5 (4 votes) |
| Healthcare Prof: |  |
2.5 (2 votes) |
The MS Society has welcomed the decision, which will benefit nearly 3,000 people with this form of MS.
Simon Gillespie, chief executive of the MS Society, said: "We welcome confirmation of NICE's decision to approve Tysabri, which represents a vital treatment option for people with highly active relapsing remitting MS.
"The health trusts now have three months to make Tysabri available and we hope there are no unnecessary delays.
Simon added: "We will be keeping a close eye on prescribing to make sure that people who stand to benefit from Tysabri are able to get the drug locally and we hope no-one finds their access limited by local funding concerns."
The Scottish Medicines Consortium is currently revising its initial decision to reject funding for Tysabri. A decision is due in September.
http://www.mssociety.org.uk
Visit our multiple sclerosis section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/80713.php>
APA
http://www.medicalnewstoday.com/releases/80713.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
